MAnagement of Systolic Blood Pressure During Thrombectomy by Endovascular Route for Acute Ischaemic STROKE

NCT ID: NCT05645861

Last Updated: 2026-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

550 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-28

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke is the third most common cause of death in New Zealand and is one of the leading causes of long-term disability at all ages. A life-saving clot retrieval procedure can save lives and prevent disability of patients with ischaemic stroke who get to hospital in time. In New Zealand, 90% of clot retrieval procedures are performed under general anaesthesia. Many anaesthetic drugs can affect blood pressure (BP) and blood flow within the brain. Increasing BP during the procedure could provide additional benefits in this devastating disease. A large trial is needed to investigate BP management during clot retrieval.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Internationally stroke ranks second among all causes of disability and is adding to considerable worldwide healthcare burden. Over the last 5 years a new procedure to remove clots (Endovascular Thrombectomy - EVT) has been effective for the treatment of acute large strokes, with significant reductions in long term patient disability compared to standard treatment. However, there minimal guidance on blood pressure management during the procedure. The brain is especially vulnerable to low blood pressure during the acute stroke period due to low blood supply, impairment of how the brain regulates blood flow and further falls in blood flow to the brain. High blood pressure may be beneficial due to increased blood flow in areas at risk during this time. It could be harmful due to brain injury process, swelling, and bleeding into the brain. Conversely, relatively low blood pressure could be harmful. Current evidence is limited to large observational studies. This randomised controlled study will examine the safety and efficacy of two systolic blood pressures (SBP) management arms during general anaesthesia for EVT on outcomes in patients with acute ischaemic stroke.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Embolus Cerebral Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Participant, investigators and outcome assessors are blinded to randomization allocation using opaque envelopes.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Augmented - Systolic Blood Pressure (SBP) at 170mmHg +/- 10 mmHg

Techniques used to target SBP will not be controlled for and will be at the discretion of the procedural anaesthetist to manage blood pressure, this can include vasopressors, intravenous fluids, titration of anaesthetic maintenance drugs and use of other vasoactive drugs.

Group Type ACTIVE_COMPARATOR

Blood pressure management of Systolic Blood Pressure to maintain target range +/- 10 mmHg

Intervention Type PROCEDURE

Techniques used to target SBP will not be controlled for and will be at the discretion of the procedural anaesthetist to manage blood pressure, this can include vasopressors, intravenous fluids, titration of anaesthetic maintenance drugs and use of other vasoactive drugs.

Standard - Systolic Blood Pressure (SBP) at 140mmHg +/- 10 mmHg

Techniques used to target SBP will not be controlled for and will be at the discretion of the procedural anaesthetist to manage blood pressure, this can include vasopressors, intravenous fluids, titration of anaesthetic maintenance drugs and use of other vasoactive drugs.

Group Type ACTIVE_COMPARATOR

Blood pressure management of Systolic Blood Pressure to maintain target range +/- 10 mmHg

Intervention Type PROCEDURE

Techniques used to target SBP will not be controlled for and will be at the discretion of the procedural anaesthetist to manage blood pressure, this can include vasopressors, intravenous fluids, titration of anaesthetic maintenance drugs and use of other vasoactive drugs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood pressure management of Systolic Blood Pressure to maintain target range +/- 10 mmHg

Techniques used to target SBP will not be controlled for and will be at the discretion of the procedural anaesthetist to manage blood pressure, this can include vasopressors, intravenous fluids, titration of anaesthetic maintenance drugs and use of other vasoactive drugs.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with anterior circulation stroke (ICA or proximal M1 or M2 segment of MCA) treated with ECR within 6 hrs of stroke onset and ECR patients presenting within 6-24 hours and favourable penumbra on perfusion scanning (see criteria 1-3).

Additional criteria in the 6 to 24-hour window.

1. 'wake up' stroke; CT with no (or at most minimal) acute infarction or
2. patient 80 years or older (NIHSS of 10 and infarct volume less than 21 ml on DWI or CT perfusion-CBF)
3. patient less than 80 years (NIHSS of 10 and infarct volume less than 31 ml on DWI or CT perfusion-CBF NIHSS of 20 and infarct volume less than 51 ml on DWI or CT perfusion-CBF).

Exclusion Criteria

* Rescue"' procedures eg acute ischaemic stroke associated with major medical procedures such as coronary artery stenting and coronary artery bypass

* pre-stroke mRS\>=3
* not having GA
* terminal illness with expected survival \<1 year
* pregnancy
* cardiovascular conditions where BP targeting will be contra-indicated
* unable to participate in 3-month follow up
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Auckland City Hospital

OTHER_GOV

Sponsor Role lead

The Australian and New Zealand College of Anaesthetists (ANZCA)

UNKNOWN

Sponsor Role collaborator

Neurological Foundation of New Zealand

UNKNOWN

Sponsor Role collaborator

The University of Queensland

OTHER

Sponsor Role collaborator

Auckland Medical Research Foundation

OTHER

Sponsor Role collaborator

Auckland Hospitals Research and Endowment Fund

UNKNOWN

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Doug Campbell, Dr

Role: PRINCIPAL_INVESTIGATOR

Auckland City Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal North Shore Hospital

Sydney, New South Wales, Australia

Site Status

Gold Coast University Hospital

Southport, Queensland, Australia

Site Status

Metro South Hospital and Health Service via the Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

Auckland City Hopsital

Auckland, Auckland, New Zealand

Site Status

Christchurch Hospital

Christchurch, Canterbury, New Zealand

Site Status

Wellington Regional Hospital

Newton, Wellington Region, New Zealand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia New Zealand

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://www.anzca.edu.au/profiles/ctn-trials/underway/masterstroke-trial

Australia New Zealand College of Anaesthesia current research

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1920 PG

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

22/001

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

A+ 8173

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2119013

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

ACTRN12619001274167

Identifier Type: REGISTRY

Identifier Source: secondary_id

MasterStroke vs 1.4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.